Davis Blaine 4
4 · Protara Therapeutics, Inc. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Award
Common Stock
2022-01-03+14,100→ 15,581 total - Award
Stock Option (Right to Buy)
2022-01-03+84,800→ 84,800 totalExercise: $6.90Exp: 2032-01-02→ Common Stock (84,800 underlying)
Footnotes (2)
- [F1]The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 3, 2022.
- [F2]25% of the shares vest on the one year anniversary of January 3, 2022 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.